Cargando…

The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient

The recognition and management of life-threatening hemorrhage in the polytrauma patient poses several challenges to prehospital rescue personnel and hospital providers. First, identification of acute blood loss and the magnitude of lost volume after torso injury may not be readily apparent in the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fecher, Alison, Stimpson, Anthony, Ferrigno, Lisa, Pohlman, Timothy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541346/
https://www.ncbi.nlm.nih.gov/pubmed/34682916
http://dx.doi.org/10.3390/jcm10204793
_version_ 1784589207415554048
author Fecher, Alison
Stimpson, Anthony
Ferrigno, Lisa
Pohlman, Timothy H.
author_facet Fecher, Alison
Stimpson, Anthony
Ferrigno, Lisa
Pohlman, Timothy H.
author_sort Fecher, Alison
collection PubMed
description The recognition and management of life-threatening hemorrhage in the polytrauma patient poses several challenges to prehospital rescue personnel and hospital providers. First, identification of acute blood loss and the magnitude of lost volume after torso injury may not be readily apparent in the field. Because of the expression of highly effective physiological mechanisms that compensate for a sudden decrease in circulatory volume, a polytrauma patient with a significant blood loss may appear normal during examination by first responders. Consequently, for every polytrauma victim with a significant mechanism of injury we assume substantial blood loss has occurred and life-threatening hemorrhage is progressing until we can prove the contrary. Second, a decision to begin damage control resuscitation (DCR), a costly, highly complex, and potentially dangerous intervention must often be reached with little time and without sufficient clinical information about the intended recipient. Whether to begin DCR in the prehospital phase remains controversial. Furthermore, DCR executed imperfectly has the potential to worsen serious derangements including acidosis, coagulopathy, and profound homeostatic imbalances that DCR is designed to correct. Additionally, transfusion of large amounts of homologous blood during DCR potentially disrupts immune and inflammatory systems, which may induce severe systemic autoinflammatory disease in the aftermath of DCR. Third, controversy remains over the composition of components that are transfused during DCR. For practical reasons, unmatched liquid plasma or freeze-dried plasma is transfused now more commonly than ABO-matched fresh frozen plasma. Low-titer type O whole blood may prove safer than red cell components, although maintaining an inventory of whole blood for possible massive transfusion during DCR creates significant challenges for blood banks. Lastly, as the primary principle of management of life-threatening hemorrhage is surgical or angiographic control of bleeding, DCR must not eclipse these definitive interventions.
format Online
Article
Text
id pubmed-8541346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85413462021-10-24 The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient Fecher, Alison Stimpson, Anthony Ferrigno, Lisa Pohlman, Timothy H. J Clin Med Review The recognition and management of life-threatening hemorrhage in the polytrauma patient poses several challenges to prehospital rescue personnel and hospital providers. First, identification of acute blood loss and the magnitude of lost volume after torso injury may not be readily apparent in the field. Because of the expression of highly effective physiological mechanisms that compensate for a sudden decrease in circulatory volume, a polytrauma patient with a significant blood loss may appear normal during examination by first responders. Consequently, for every polytrauma victim with a significant mechanism of injury we assume substantial blood loss has occurred and life-threatening hemorrhage is progressing until we can prove the contrary. Second, a decision to begin damage control resuscitation (DCR), a costly, highly complex, and potentially dangerous intervention must often be reached with little time and without sufficient clinical information about the intended recipient. Whether to begin DCR in the prehospital phase remains controversial. Furthermore, DCR executed imperfectly has the potential to worsen serious derangements including acidosis, coagulopathy, and profound homeostatic imbalances that DCR is designed to correct. Additionally, transfusion of large amounts of homologous blood during DCR potentially disrupts immune and inflammatory systems, which may induce severe systemic autoinflammatory disease in the aftermath of DCR. Third, controversy remains over the composition of components that are transfused during DCR. For practical reasons, unmatched liquid plasma or freeze-dried plasma is transfused now more commonly than ABO-matched fresh frozen plasma. Low-titer type O whole blood may prove safer than red cell components, although maintaining an inventory of whole blood for possible massive transfusion during DCR creates significant challenges for blood banks. Lastly, as the primary principle of management of life-threatening hemorrhage is surgical or angiographic control of bleeding, DCR must not eclipse these definitive interventions. MDPI 2021-10-19 /pmc/articles/PMC8541346/ /pubmed/34682916 http://dx.doi.org/10.3390/jcm10204793 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fecher, Alison
Stimpson, Anthony
Ferrigno, Lisa
Pohlman, Timothy H.
The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title_full The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title_fullStr The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title_full_unstemmed The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title_short The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient
title_sort pathophysiology and management of hemorrhagic shock in the polytrauma patient
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541346/
https://www.ncbi.nlm.nih.gov/pubmed/34682916
http://dx.doi.org/10.3390/jcm10204793
work_keys_str_mv AT fecheralison thepathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT stimpsonanthony thepathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT ferrignolisa thepathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT pohlmantimothyh thepathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT fecheralison pathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT stimpsonanthony pathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT ferrignolisa pathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient
AT pohlmantimothyh pathophysiologyandmanagementofhemorrhagicshockinthepolytraumapatient